Skip to main content

Sodium Fluorescein

Sodium fluorescein is a fluorescent xanthene dye that emits a yellow-green color under blue (490 nm) or ultraviolet light, visible even at very low concentrations in urine. In GU practice it has a niche role as an IV ureteral-identification agent and as an intravesical leak-detection dye — filling the gap left by indigo carmine shortages and serving as a low-cost alternative to NIR fluorophores in centers without NIR imaging.[1]


Pharmacology

PropertyValue
ClassXanthene fluorescent dye
ColorYellow-green (visible), intensifies under blue/UV light
RouteIV or intravesical
Renal excretionRapid glomerular filtration → visible in urine within 5–15 minutes of IV dose
Duration30–60 minutes of visible urinary fluorescence
FDA approvalFLUORESCITE: retinal/iris angiography or angioscopy; GU use is off-label, not approved “by extension”

GU Applications

1. IV ureteral identification during MIS / open pelvic surgery

  • 25–50 mg IV (diluted) produces visible yellow-green urinary efflux within 5–15 minutes
  • Particularly useful when indigo carmine is unavailable and NIR imaging is not in place
  • Doyle et al. 2015 described 25–100 mg IV for ureteral efflux; the later Grimes randomized trial used 25 mg. These are off-label study regimens, not the labeled ophthalmic dose.[1][2]

2. Intravesical applications

Intravesical use is off-label and lacks a standardized regimen established by the cited IV-efflux studies. Do not transfer an IV or ophthalmic preparation into the bladder without an appropriate local protocol and pharmacy review.

3. Perfusion / angiography (limited GU use)

  • Widely used in ophthalmology for retinal angiography
  • Occasional intraoperative use for flap perfusion assessment in plastic surgery
  • Rare in GU reconstruction (ICG preferred for perfusion)

Dosing

  • IV ureteral identification: 25–50 mg IV (dilute in 10 mL saline, give slowly)
  • Intravesical leak testing: use a locally reviewed protocol; the IV studies do not establish a bladder dose.
  • Verify the supplied concentration: FLUORESCITE 10% is 100 mg/mL. GU studies used much less than the labeled 500 mg adult ophthalmic dose.[3]

Adverse Events

  • Skin yellowing — transient
  • Yellow urine — expected, resolves in 24 hours
  • Nausea, vomiting — occasional at higher doses
  • Hypersensitivity, including fatal anaphylaxis — known fluorescein/component hypersensitivity is a contraindication; low-dose GU use does not establish freedom from this risk. Have emergency treatment available.
  • Extravasation can cause severe tissue damage; confirm a functioning IV.[3]
  • Fluorescent/colorimetric assays may be affected; notify the laboratory of recent dye administration

Sodium Fluorescein vs. Indigo Carmine vs. Methylene Blue

FeatureSodium FluoresceinIndigo CarmineMethylene Blue
ColorYellow-greenBlue-violetDeep blue
Visible in urineYes (enhanced under UV/blue)YesYes
Best useAlternative to indigo carmine when unavailableCystoscopic ureteral-efflux aidFistula / orifice / anastomotic leak
AvailabilityConsistentBLUDIGO marketed; check local supplyConsistent
CostLowLowVery low
Need for special imagingEnhanced by blue filter (optional)NoneNone

See Also


References

1. Doyle PJ, Lipetskaia L, Duecy E, Buchsbaum G, Wood RW. Sodium fluorescein use during intraoperative cystoscopy. Obstet Gynecol. 2015;125(3):548–550. doi:10.1097/AOG.0000000000000675

2. Grimes CL, Patankar S, Ryntz T, et al. Evaluating ureteral patency in the post-indigo carmine era: a randomized controlled trial. Am J Obstet Gynecol. 2017;217(5):601.e1–601.e10. doi:10.1016/j.ajog.2017.07.012.

3. FLUORESCITE. US prescribing information, revised June 2026. DailyMed.